calcitriol
- ANI PharmaceuticalsMade by Esjay Pharma, the company behind Rocaltrol
-
1 mcg/mLsolution
-
70954-831-1011-digit: 70954-0831-1015 mL per bottle
-
Source: FDA, updated October 30, 2026
Generic name: calcitriol
Used for: High parathyroid hormone from kidney disease · Low calcium in people on dialysis · Low calcium from parathyroid problems (hypoparathyroidism) · 2 more
From
$12.45 for 30 capsules delivered ($7.20 plus $5.25 shipping)
Generic calcitriol from Cost Plus Drugs, by mail. Pick the strength on your label above for its own price.
Need it today? From $15.64 for 30 capsules with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.
See the price and get the cardWith a membership From $9.13 for 30 capsules from Amazon Pharmacy, by mail ($139 a year).
Open Amazon PharmacyA regular generic has the same active ingredient as Rocaltrol, and the FDA requires it to work the same way.
Details for each option
Rocaltrol itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.
The same medicine as Rocaltrol, without the brand name. Give the pharmacy its NDC to get it.
calcitriol
Source: FDA, updated October 30, 2026
“Before you fill my Rocaltrol, can you tell me what I’d pay for the brand, for the authorized generic from ANI Pharmaceuticals (NDC 70954-831-10), and for a regular generic?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).
Rocaltrol itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.
Active: calcitriol 1 mcg/mL
Inactive:
Pharmacies’ own cash prices for generic calcitriol, lowest first.
Pick up in storeDelivered
From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.
Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.
8 companies sell a generic of Rocaltrol that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Has dyes: FD&C Red No. 3, FD&C Yellow No. 6 · Made by Onesource Specialty Pharma
Product page on avetpharma.com
0.25 mcg Orange, oval, 10 mm, marked “673”
| Package | NDC |
|---|---|
| Bottle of 30 | 23155-662-03 |
| Bottle of 100 | 23155-662-01 |
0.5 mcg Orange, capsule, 13 mm, marked “674”
| Package | NDC |
|---|---|
| Bottle of 100 | 23155-663-01 |
Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, glycerin, sorbitol, FD&C Yellow No. 6, FD&C Red No. 3, titanium dioxide, propylene glycol, shellac, isopropyl alcohol, butyl alcohol, ammonia, ferrosoferric oxide
Has dyes: FD&C Red No. 40, FD&C Yellow No. 6
Product page on bionpharma.com
0.25 mcg Light orange, oval, 10 mm, marked “CAL1”
| Package | NDC |
|---|---|
| Bottle of 30 | 69452-207-13 |
| Bottle of 100 | 69452-207-20 |
0.5 mcg Dark orange-red, oval, 10 mm, marked “CAL2”
| Package | NDC |
|---|---|
| Bottle of 30 | 69452-208-13 |
| Bottle of 100 | 69452-208-20 |
Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, gelatin, glycerin, sorbitol, sorbitan, mannitol, water, FD&C Yellow No. 6, FD&C Red No. 40, titanium dioxide, ferrosoferric oxide
Has dyes: FD&C Red No. 3, FD&C Yellow No. 6 · Made by Onesource Specialty Pharma
0.25 mcg Orange, oval, 10 mm, marked “673”
| Package | NDC |
|---|---|
| Bottle of 90 | 62135-610-90 |
0.5 mcg Orange, capsule, 13 mm, marked “674”
| Package | NDC |
|---|---|
| Bottle of 90 | 62135-611-90 |
Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, glycerin, sorbitol, FD&C Yellow No. 6, FD&C Red No. 3, titanium dioxide
Has a dye: FD&C Yellow No. 6 · Made by Humanwell Puracap Pharmaceutical Wuhan
Product page on epic-pharma.com
0.25 mcg Opaque light orange, capsule, 9 mm, marked “P1”
| Package | NDC |
|---|---|
| Bottle of 100 | 42806-732-01 |
0.5 mcg Opaque light orange, capsule, 12 mm, marked “P2”
| Package | NDC |
|---|---|
| Bottle of 100 | 42806-733-01 |
Inactive ingredients: butylated hydroxytoluene, medium-chain triglycerides, glycerin, noncrystallizing sorbitol solution, butylated hydroxyanisole, gelatin, FD&C Yellow No. 6, titanium dioxide, alcohol
1 mcg/mL
| Package | NDC |
|---|---|
| Carton of 15 mL | 0054-3120-41 |
Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, omega-3-acid ethyl esters
1 mcg/mL
| Package | NDC |
|---|---|
| Carton of 15 mL | 64980-447-15 |
Inactive ingredients: medium-chain triglycerides, butylated hydroxyanisole, butylated hydroxytoluene
Has dyes: FD&C Red No. 3, FD&C Yellow No. 6 · Made by Onesource Specialty Pharma
Product page on stridespharmausa.com
0.25 mcg Orange, oval, 10 mm, marked “673”
| Package | NDC |
|---|---|
| Container of 30 | 64380-723-04 |
| Container of 100 | 64380-723-06 |
0.5 mcg Orange, capsule, 13 mm, marked “674”
| Package | NDC |
|---|---|
| Container of 100 | 64380-724-06 |
Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, glycerin, noncrystallizing sorbitol solution, FD&C Yellow No. 6, FD&C Red No. 3, titanium dioxide, propylene glycol, shellac, ferrosoferric oxide, isopropyl alcohol, butyl alcohol, ammonia
Being phased out; sold until February 2027
0.25 mcg Red-brown and yellow-brown, oval, 10 mm, marked “93 / 657”
| Package | NDC |
|---|---|
| Bottle of 100 | 0093-7352-01 |
0.5 mcg Brown and pink, oval, 13 mm, marked “93 / 658”
| Package | NDC |
|---|---|
| Bottle of 100 | 0093-7353-01 |
Inactive ingredients: butylated hydroxyanisole, butylated hydroxytoluene, medium-chain triglycerides, gelatin, glycerin, mannitol, ferric oxide red, sorbitol, titanium dioxide, ferric oxide yellow, propylene glycol
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
Predialysis Patients
Calcitriol is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥ 100 pg/mL is strongly suggestive of secondary hyperparathyroidism.
Dialysis Patients
Calcitriol is indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization.
Hypoparathyroidism Patients
Calcitriol is also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism.
Source: the FDA label for Calcitriol (ANI Pharmaceuticals, Inc.), July 10, 2026. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/rocaltrol/